CAIX is a predictor of pathological complete response and is associated with higher survival in locally advanced breast cancer submitted to neoadjuvant chemotherapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
CAIX is a predictor of pathological complete response and is associated with higher survival in locally advanced breast cancer submitted to neoadjuvant chemotherapy ; volume:19 ; number:1 ; day:3 ; month:12 ; year:2019 ; pages:1-11 ; date:12.2019
BMC cancer ; 19, Heft 1 (3.12.2019), 1-11, 12.2019
- Creator
-
Alves, Wilson Eduardo Furlan Matos
Bonatelli, Murilo
Dufloth, Rozany
Kerr, Lígia Maria
Carrara, Guilherme Freire Angotti
Costa, Ricardo Filipe Alves da
Scapulatempo-Neto, Cristovam
Tiezzi, Daniel
Costa Vieira, René Aloísio da
Pinheiro, Céline
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-019-6353-2
- URN
-
urn:nbn:de:101:1-2020032620414869572012
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Alves, Wilson Eduardo Furlan Matos
- Bonatelli, Murilo
- Dufloth, Rozany
- Kerr, Lígia Maria
- Carrara, Guilherme Freire Angotti
- Costa, Ricardo Filipe Alves da
- Scapulatempo-Neto, Cristovam
- Tiezzi, Daniel
- Costa Vieira, René Aloísio da
- Pinheiro, Céline
- SpringerLink (Online service)
Other Objects (12)
Prognostic assessment of breast carcinoma submitted to neoadjuvant chemotherapy with pathological non-complete response
Clinical tumor stage is the most important predictor of pathological complete response rate after neoadjuvant chemotherapy in breast cancer patients
Mucinous histology is a negative predictor of neoadjuvant chemoradiotherapy for locally advanced rectal adenocarcinoma
Mammographic density is a potential predictive marker of pathological response after neoadjuvant chemotherapy in breast cancer
Is insulin resistance a predictor for complete response in breast cancer patients who underwent neoadjuvant treatment?
Is the Post-Radical Prostatectomy Gleason Score a Valid Predictor of Mortality after Neoadjuvant Hormonal Treatment?
Why is LCIS Important—Pathological Review
NOXA expression is downregulated in human breast cancer undergoing incomplete pathological response and senescence after neoadjuvant chemotherapy
Obesity is associated with early recurrence on breast cancer patients that achieved pathological complete response to neoadjuvant chemotherapy
Pretreatment systemic inflammation response index is predictive of pathological complete response in patients with breast cancer receiving neoadjuvant chemotherapy
Pathological evaluation of neoadjuvant chemotherapy in advanced gastric cancer
HIV is an independent predictor of aortic stiffness
Prognostic assessment of breast carcinoma submitted to neoadjuvant chemotherapy with pathological non-complete response
Clinical tumor stage is the most important predictor of pathological complete response rate after neoadjuvant chemotherapy in breast cancer patients
Mucinous histology is a negative predictor of neoadjuvant chemoradiotherapy for locally advanced rectal adenocarcinoma
Mammographic density is a potential predictive marker of pathological response after neoadjuvant chemotherapy in breast cancer
Is insulin resistance a predictor for complete response in breast cancer patients who underwent neoadjuvant treatment?
Is the Post-Radical Prostatectomy Gleason Score a Valid Predictor of Mortality after Neoadjuvant Hormonal Treatment?
Why is LCIS Important—Pathological Review
NOXA expression is downregulated in human breast cancer undergoing incomplete pathological response and senescence after neoadjuvant chemotherapy
Obesity is associated with early recurrence on breast cancer patients that achieved pathological complete response to neoadjuvant chemotherapy
Pretreatment systemic inflammation response index is predictive of pathological complete response in patients with breast cancer receiving neoadjuvant chemotherapy
Pathological evaluation of neoadjuvant chemotherapy in advanced gastric cancer
HIV is an independent predictor of aortic stiffness
Prognostic assessment of breast carcinoma submitted to neoadjuvant chemotherapy with pathological non-complete response
Clinical tumor stage is the most important predictor of pathological complete response rate after neoadjuvant chemotherapy in breast cancer patients
Mucinous histology is a negative predictor of neoadjuvant chemoradiotherapy for locally advanced rectal adenocarcinoma
Mammographic density is a potential predictive marker of pathological response after neoadjuvant chemotherapy in breast cancer
Is insulin resistance a predictor for complete response in breast cancer patients who underwent neoadjuvant treatment?
Is the Post-Radical Prostatectomy Gleason Score a Valid Predictor of Mortality after Neoadjuvant Hormonal Treatment?
Why is LCIS Important—Pathological Review
NOXA expression is downregulated in human breast cancer undergoing incomplete pathological response and senescence after neoadjuvant chemotherapy
Obesity is associated with early recurrence on breast cancer patients that achieved pathological complete response to neoadjuvant chemotherapy
Pretreatment systemic inflammation response index is predictive of pathological complete response in patients with breast cancer receiving neoadjuvant chemotherapy
Pathological evaluation of neoadjuvant chemotherapy in advanced gastric cancer